Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Fusie Lymph&Co, 2,6 miljoen euro extra voor wetenschappelijk onderzoek
feb 2018 | Lymfoom